SEARCH HEALTH CONDITIONS BY ALPHABETS
Factor IX Hemophilia
Medications for Factor IX Deficiency
Other names: Xmas Disease; Factor IX Hemophilia
About Factor IX Deficiency: Factor IX Deficiency additionally known as Hemophilia B, has been a blood clotting disease, caused by a congenital deficiency of factor IX.
Drugs Used in the Treatment of Factor IX Deficiency
This listing of medications come in some way associated with, or used in the treating this particular condition.
Drug name | Rx / OTC | Pregnancy | CSA | Alcohol | Reviews | Rating | Popularity |
---|---|---|---|---|---|---|---|
BeneFix | Rx | C | N | 1 inspection | 6.0 | ||
Generic title: coagulation factor ix systemic Drug class: miscellaneous coagulation modifiers For customers: dosage, interactions, side effects For professionals: AHFS DI Monograph, Prescribing Information | |||||||
Cyklokapron | Rx | B | N | 1 inspection | 9.0 | ||
Generic title: tranexamic acid systemic Drug class: miscellaneous coagulation modifiers For customers: dosage, interactions, side effects For professionals: Prescribing Information | |||||||
Profilnine SD | Rx | C | N | Add inspection | 0.0 | ||
Generic title: factor ix complex systemic Drug class: miscellaneous coagulation modifiers For customers: dosage, interactions, side effects For professionals: Prescribing Information | |||||||
coagulation factor ix | Rx | C | N | 1 inspection | 6.0 | ||
Generic title: coagulation factor ix systemic Brand names: BeneFix, Alphanine SD, Mononine Drug class: miscellaneous coagulation modifiers For customers: dosage, interactions, For professionals: Az Drug Facts, AHFS DI Monograph | |||||||
tranexamic acid | Rx | B | N | 1 inspection | 9.0 | ||
Generic title: tranexamic acid systemic Brand title: Cyklokapron Drug class: miscellaneous coagulation modifiers For customers: dosage, interactions, For professionals: Az Drug Facts, Prescribing Information | |||||||
Alphanine SD | Rx | C | N | Add inspection | 0.0 | ||
Generic title: coagulation factor ix systemic Drug class: miscellaneous coagulation modifiers For customers: dosage, interactions, side effects For professionals: Prescribing Information | |||||||
factor ix complicated | Rx | C | N | Add inspection | 0.0 | ||
Generic title: factor ix complex systemic Brand names: Profilnine SD, Bebulin Drug class: miscellaneous coagulation modifiers For customers: dosage, interactions, For professionals: Az Drug Facts | |||||||
Mononine | Rx | C | N | Add inspection | 0.0 | ||
Generic title: coagulation factor ix systemic Drug class: miscellaneous coagulation modifiers For customers: dosage, interactions, side effects For professionals: Prescribing Information | |||||||
Bebulin | Rx | C | N | Add inspection | 0.0 | ||
Generic title: factor ix complex systemic For users: dosage, interactions, side effects | |||||||
Legend
Rx | prescription-only |
---|---|
OTC | Over the Counter |
Rx/OTC | Prescription or Over the Counter |
Off Label | This drug might well not be approved by the FDA for the treatment of the particular condition. |
Pregnancy Category | |
---|---|
A | Adequate and well-controlled studies have failed to demonstrate a risk to the fetus within the first trimester of pregnancy (and there isn`t any evidence of risk in later trimesters). |
B | Animal reproduction studies have failed to show a risk to the fetus and there are no sufficient and well-controlled studies in pregnant women. |
C | Animal reproduction studies have shown a negative effect on the fetus and there are no sufficient and well-controlled studies in humans, but potential benefits may warrant use in pregnant women despite potential risks. |
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but potential benefits may justify use in pregnant women despite potential risks. |
X | Studies in animals or humans have demonstrated fetal abnormalities or there is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience, and the risks involved with use in pregnant women obviously outweigh potential rewards. |
N | FDA have not classified this drug. |
Controlled Substances Act (CSA) Program | |
---|---|
N | isn`t at the mercy of the Controlled Substances Act. |
1 | Has a high possibility of misuse. Has no accepted medical use in treatment in the United States. There is just a lack of accepted safety for use under medical supervision. |
2 | Has a high possibility of misuse. Features a currently accepted medical use in treatment in the United States or a currently accepted medical use with severe restrictions. Abuse may result in severe physical or emotional dependence. |
3 | features a possibility for abuse less than individuals in schedules 1 and two. Features a currently accepted medical use in treatment in the United States. Abuse may lead to physical dependence or high psychological dependence. |
4 | Has a very low potential for abuse in accordance with individuals in program 3. It`s a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to individuals in program 3. |
5 | Has a very low potential for abuse in accordance with individuals in program 4. Features a currently accepted medical use in treatment in the United States. Abuse may lead to limited physical dependence or psychological dependence relative to individuals in program 4. |
Alcohol | |
---|---|
X | Interacts with Alcohol. |
Browse Treatment Options
- A
- B
- C
- D
- E
- F
- G
- H
- I
- J
- K
- L
- M
- N
- O
- P
- Q
- Dtc
- S
- T
- U
- V
- W
- X
- Y
- Z
Further info
Always seek advice from your healthcare provider to be sure the information applies to your circumstances.